Clinical Trial

Effects of tDCS on Fear Reversal in Patients With Anxiety Disorders

Enrolling by Invitation
View on ClinicalTrials.gov →
Summary
This study evaluates the effects of single-session Transcranial Direct Current Stimulation (tDCS) on fear reversal learning in patients with anxiety disorders. Participants will be randomized into four groups to receive either active stimulation targeting specific brain regions (right DLPFC or vmPFC), an active control stimulation, or sham stimulation. The main goal is to determine if modulating these brain areas can improve the ability to update safety and threat associations.
Trial Details
NCT Number NCT07405463
Lead Sponsor Jingchu Hu
Conditions Anxiety Disorders
Enrollment 140 participants
Start Date 2025-12-01
Primary Completion 2028-12-01 (estimated)
Study Completion 2028-12-01 (estimated)
Updated on ClinicalTrials.gov 2026-02-12